CNS Pharmaceuticals, Inc. (CNSP) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for CNS Pharmaceuticals, Inc. (CNSP).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $7.42

Daily Change: -$0.0321 / 0.43%

Daily Range: $6.83 - $7.53

Market Cap: $3,703,504

Daily Volume: 27,692

Performance Metrics

1 Week: -12.41%

1 Month: -38.03%

3 Months: -48.22%

6 Months: -87.93%

1 Year: -94.00%

YTD: -90.32%

Company Details

Employees: 5

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Selected stocks

Barinthus Biotherapeutics plc (BRNS)

AquaBounty Technologies, Inc. (AQB)

Moderna, Inc. (MRNA)